130 related articles for article (PubMed ID: 8747719)
21. Differential sensitivity to transforming growth factor (TGF)-beta of CBA and of CBA/N B cells demonstrates that the IgG2b inducing factor in synovial fluid from rheumatoid arthritis patients is not identical to TGF-beta.
Ridderstad A; Lettesjö H; Abedi-Valugerdi M; Möller E
Int Immunol; 1995 Mar; 7(3):459-69. PubMed ID: 7794824
[TBL] [Abstract][Full Text] [Related]
22. Modulation of B-cell abnormalities in lupus-prone (NZB x NZW)F1 mice by normal bone marrow-derived B-lineage cells.
Shao DZ; Yamada S; Hirayama F; Hirano H; Ono S; Hamaoka T
Immunology; 1995 May; 85(1):16-25. PubMed ID: 7635516
[TBL] [Abstract][Full Text] [Related]
23. [Effects of high and low molecular soluble factors of the bone marrow on antibody formation and pain sensitivity in animals].
Ianovskiĭ OG; Zakharova LA; Vasilenko AM
Biull Eksp Biol Med; 1990 Jan; 109(1):55-7. PubMed ID: 2334799
[TBL] [Abstract][Full Text] [Related]
24. Immunosuppressive activity of some peptides related to cycloamanide A (CyA A) and to the active fragment of a peptide immunomodulator from ovine colostrum.
Bolewska-Pedyczak E; Wieczorek Z; Zimecki M; Siemion IZ
Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):297-301. PubMed ID: 8010869
[TBL] [Abstract][Full Text] [Related]
25. Effects of prostaglandin E1 on the production of IgM and IgG class anti-dsDNA antibodies in NZB/W F1 mice.
Yoshikawa T; Suzuki H; Sugiyama E; Tunru IS; Ikemoto M; Hori T; Matsui S; Yamashita N; Kobayashi M
J Rheumatol; 1993 Oct; 20(10):1701-6. PubMed ID: 8295181
[TBL] [Abstract][Full Text] [Related]
26. Studies of congenitally immunologically mutant New Zealand mice. IX. Age-related microenvironmental effects on autoantibody production in NZB and NZB.Xid mice studied by transplantation.
Bray KR; Gershwin ME; Skelly RR; Ahmed A; Kincade PW
J Immunol; 1984 Jun; 132(6):2913-8. PubMed ID: 6373922
[TBL] [Abstract][Full Text] [Related]
27. Myelopeptides effect on longevity and immunological parameters in mice with congenital immunodeficiency.
Mikhailova AA; Sorokin SV; Komponiec NA
Ann Ist Super Sanita; 1991; 27(1):57-60. PubMed ID: 1958029
[TBL] [Abstract][Full Text] [Related]
28. The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice.
Hayakawa K; Hardy RR; Parks DR; Herzenberg LA
J Exp Med; 1983 Jan; 157(1):202-18. PubMed ID: 6600267
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the requirements for cognate T cell help for IgG anti-double-stranded DNA antibody production in vitro: T helper-derived lymphokines replace T cell cloned lines for B cells from NZB.H-2bm12 but not B6.H-2bm12 mice.
Cawley D; Chiang BL; Naiki M; Ansari AA; Gershwin ME
J Immunol; 1993 Mar; 150(6):2467-77. PubMed ID: 8450223
[TBL] [Abstract][Full Text] [Related]
30. Loss of suppressor T cells in adult NZB/NZW mice.
Krakauer RS; Waldmann TA; Strober W
J Exp Med; 1976 Sep; 144(3):662-73. PubMed ID: 1085336
[TBL] [Abstract][Full Text] [Related]
31. [Synthesis and properties of the retro-analogue of myelopeptide MP-2].
Fonina LA; Ovchinnikov MV; Gur'ianov SA; Sychev SV; Belevskaia RG; Treshchalina EM
Bioorg Khim; 2005; 31(3):239-44. PubMed ID: 16004381
[TBL] [Abstract][Full Text] [Related]
32. [Suppressive action of bone marrow and spleen cells on antibody genesis and lymphoid cell proliferation in an in vitro culture of autoimmune mice (NZB.NZW)F1].
Petrov RV; Nasonova VA; Khaitov RM; Nazhmetdinov AM; Pchelintsev SIu
Tsitologiia; 1981 Jul; 23(7):834-8. PubMed ID: 7281233
[TBL] [Abstract][Full Text] [Related]
33. Abrogation of pathogenic IgG autoantibody production in CD40L gene-deleted lupus-prone New Zealand Black mice.
Pau E; Chang NH; Loh C; Lajoie G; Wither JE
Clin Immunol; 2011 May; 139(2):215-27. PubMed ID: 21414847
[TBL] [Abstract][Full Text] [Related]
34. Serum-mediated suppression of nonspecific B cell activation. II. Relative resistance of B cells from the NZB mouse strain to regulation by a natural inhibitor in normal mouse serum.
Walker SM; Sturtevant JE; Weigle WO
J Immunol; 1981 Sep; 127(3):1204-7. PubMed ID: 6973581
[TBL] [Abstract][Full Text] [Related]
35. A novel function of B lymphocytes from normal mice to suppress autoimmunity in (NZB x NZW)F1 mice.
Ono S; Shao D; Yamada S; Yang Y; Yamashita M; Hamaoka T
Immunology; 2000 May; 100(1):99-109. PubMed ID: 10809965
[TBL] [Abstract][Full Text] [Related]
36. [Myelopeptide-1 stimulates humoral immune response in irradiated mice].
Shanurin SIu
Radiats Biol Radioecol; 1994; 34(4-5):509-13. PubMed ID: 7951877
[TBL] [Abstract][Full Text] [Related]
37. Immunomodulating activity of myelopeptides: clinical trials.
Petrov RV
Ann N Y Acad Sci; 1993 Jun; 685():351-61. PubMed ID: 8363240
[TBL] [Abstract][Full Text] [Related]
38. In vitro responses of CBA/N mice: spleen cells of mice with an X-linked defect that precludes immune responses to several thymus-independent antigens can respond to TNP-lipopolysaccharide.
Mosier DE; Scher I; Paul WE
J Immunol; 1976 Oct; 117(4):1363-9. PubMed ID: 789772
[TBL] [Abstract][Full Text] [Related]
39. Polyclonal activation of the murine immune system by an antibody to IgD. IV. In vivo activation of B lymphocytes from immune defective CBA/N mice.
Muul LM; Scher I; Mond JJ; Finkelman FD
J Immunol; 1983 Nov; 131(5):2226-31. PubMed ID: 6605378
[TBL] [Abstract][Full Text] [Related]
40. Polyclonal antibody synthesis by bone marrow cells of New Zealand black mice. I. Assessment of activity in an adoptively transferred histocompatible host.
Fujiwara M; Katagiri T
Int Arch Allergy Appl Immunol; 1982; 69(3):272-8. PubMed ID: 6982236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
